STOP-AKI (2018) — Trial Summary
STOP-AKI (2018): Evaluated the efficacy of recombinant alkaline phosphatase in patients with sepsis-associated acute kidney injury.
References
- Pickkers P, Mehta RL, Murray PT, et al. Effect of Human Recombinant Alkaline Phosphatase on 7-Day Creatinine Clearance in Patients With Sepsis-Associated Acute Kidney Injury: A Randomized Clinical Trial. JAMA. 2018;320(19):1998-2009.